Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ZymoGenetics Snags $70M Payout From BMS For Phase II Start Of New Interferon

This article was originally published in The Pink Sheet Daily

Executive Summary

A trial will evaluate PEG-Interferon lambda - a drug Bristol includes among its "string of pearls" - versus Pegasys for the treatment of hepatitis C.
Advertisement

Related Content

From HCV Partner To Acquirer, BMS Makes $885 M Offer for ZymoGenetics
From HCV Partner To Acquirer, BMS Makes $885 M Offer for ZymoGenetics
Sponsors Caution Against Premature Expanded Access For Novel HCV Drugs
Sponsors Caution Against Premature Expanded Access For Novel HCV Drugs
Refocusing ZymoGenetics Cuts Staff, Seeds Pipeline Of Private Startup Firm
Vertex And Schering Hold Hep C Lead, But Others Look To Deal Themselves In
Co-Development Deal Brings Bristol A Novel Interferon, ZymoGenetics Much-Needed Cash
Co-Development Deal Brings Bristol A Novel Interferon, ZymoGenetics Much-Needed Cash

Topics

Advertisement
UsernamePublicRestriction

Register

PS068666

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel